TextSearch

Cases of myocarditis – an inflammation of the heart muscle – following a third dose of the Pfizer vaccine are rare and typically mild, research from Israel shows.

Myocarditis from COVID-19 booster rare, but risk highest among teen boys, young men | American Heart Association Skip to main content Heart Attack and Stroke Symptoms Volunteer SHOP DONATE ONCE DONATE MONTHLY Donate Now Search × Search ClearSearchLoading Menu Search American Heart Association Search" Heart Attack And Stroke Symptoms Volunteer Donate Now SHOP In Your Community Zip Code or State State AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareDistrict of ColumbiaFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaPuerto RicoRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWest VirginiaWisconsinWyoming Search Healthy Living Healthy Living Healthy Eating Recipes Healthy Lifestyle Fitness Pets and Your Health / Healthy Bond for Life Company Collaboration Well-being Works Better™ Health Topics Health Topics Aortic Aneurysm Arrhythmia Atrial Fibrillation Cardiac Arrest Cardiac Rehab Cardiomyopathy Cholesterol Congenital Heart Defects Diabetes Flu Prevention Heart Attack Heart Failure Heart Murmurs Heart Valve Problems and Disease High Blood Pressure Infective Endocarditis Kawasaki Disease Metabolic Syndrome Myocarditis Pericarditis Peripheral Artery Disease Sleep Disorders Stroke Venous Thromboembolism Consumer Health Care Caregiver Support Support Network Professionals Professional Resources Professional Heart Daily Research Professional Membership Meetings Education Guidelines & Statements Journals Quality Improvement Educators and Parents National Hypertension Control Initiative Million Hearts Collaboration About Us About Us Our Impact Our Lifesaving History Heart and Stroke News Noticias en español CEO Roundtable Policy Research Scientific Research International Programs 2024 Health Equity Impact Goal Equitable Health for All Value in Healthcare Initiative Media Newsroom Annual Report AHA Financial Information Content Editorial Guidelines Contact Us Career Opportunities Get Involved Get Involved Volunteer Find an Event Near You Advocate Go Red For Women Research Goes Red SHOP Ways To Give Ways to Give Monthly Giving As Seen On TV Honor a Loved One Make a Memorial Gift Create a Tribute Page Raise Your Way Gifts of Stock and Mutual Funds Donor Advised Fund Wills Trusts and Annuities Fundraising Events Cor Vitae Society Paul Dudley White Legacy Society Kids Heart Challenge American Heart Challenge Social Impact Fund Heritage Brick Walk Retail Supporters CPR CPR and First Aid Find A Training Center Find A Course CPR Purchase Options Healthy Living Healthy Living Healthy Eating Add Color Cooking Skills Eat Smart Heart-Check Foods Losing Weight Recipes Healthy Lifestyle Mental Health and Well-being Sleep Stress Management Quit Smoking/Tobacco/Vaping Healthy Habits Fitness Fitness Basics Getting Active Staying Motivated Walking Pets and Your Health / Healthy Bond for Life Best Friend Fridays Horses Have Heart Company Collaboration Well-being Works Better™ Heart-Check Certification Food System Strategy Healthy for Life Health Equity in the Workforce Health Topics Health Topics Aortic Aneurysm Arrhythmia Atrial Fibrillation Cardiac Arrest Cardiac Rehab Cardiomyopathy Cholesterol Congenital Heart Defects Diabetes Flu Prevention Heart Attack Heart Failure Heart Murmurs Heart Valve Problems & Disease High Blood Pressure Infective Endocarditis Kawasaki Disease Metabolic Syndrome Myocarditis Pericarditis Peripheral Artery Disease Sleep Disorders Stroke Venous Thromboembolism Caregiver Support Consumer Health Care Support Network Coronavirus (COVID-19) Professionals Professional Resources Professional Heart Daily Research Professional Membership Meetings Education Guidelines & Statements Journals Communities Science News Quality Improvement Get With The Guidelines® Mission: Lifeline® Healthcare Certification Outpatient Quality Improvement International Quality Care Research and Publications Target: Heart Failure℠ Target: Stroke℠ Target: Aortic Stenosis™ Hemorrhagic Stroke Initiative Mitral Valve Reference Center Award Rural Health Care Outcomes Accelerator Educators and Parents Kids Health Initiatives School Programs NFL PLAY 60 Teaching Gardens National Hypertension Control Initiative La Iniciativa Nacional de Control de la Hipertensión Million Hearts Collaboration® Doctors With Heart Get Involved Get Involved Volunteer Find an Event Near You Advocate Federal Priorities State Issues Heart on the Hill Media Advocacy Policy Research Go Red For Women Research Goes Red For Companies SHOP Ways to Give Ways to Give Monthly Giving As Seen On TV Honor a Loved One Make a Memorial Gift Create a Tribute Page Gifts of Stock and Mutual Funds Donor Advised Fund Wills Trusts and Annuities Fundraising Events Cor Vitae Society Paul Dudley White Legacy Society Raise Your Way Kids Heart Challenge Social Impact Fund Heritage Brick Walk Retail Supporters American Heart Challenge About Us About Us Our Lifesaving History Our Impact Equitable Health for All 2024 Health Equity Impact Goal CEO Roundtable Scientific Research Value in Healthcare Initiative AHA Financial Information Office of Health Equity Bernard J Tyson Fund Diversity and Inclusion EmPOWERED to Serve Health Ecosystems Social Impact Fund Health Equity in the Workforce Heart & Stroke News Noticias en español Content Editorial Guidelines Podcast Network Policy Research Advocacy Fact Sheets Policy Positions International Programs International Gold Standard Confidence CPR Lifesavers in India Media Newsroom Career Opportunities Annual Report Contact Us CPR CPR and First Aid Find A Training Center Find A Course CPR Purchase Options In Your Community Zip Code or State State AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareDistrict of ColumbiaFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaPuerto RicoRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWest VirginiaWisconsinWyoming Search Volunteer Learn CPR SHOP Heart Attack and Stroke Symptoms Home News Myocarditis from COVID-19 booster rare, but risk highest among teen boys, young men Published: September 6, 2022 Myocarditis from COVID-19 booster rare, but risk highest among teen boys, young men By American Heart Association News (Jolygon/iStock via Getty Images) The risk of developing myocarditis – an inflammation of the heart muscle – following a booster dose of the Pfizer COVID-19 vaccine is low, according to new research from Israel. When vaccine-related myocarditis does occur, cases are typically mild, according to the study published Tuesday in the American Heart Association journal Circulation. It found the risk was highest among teen boys and young men. "It is important to understand the connections between this rare heart condition and COVID-19 vaccines so we can monitor the prevalence of myocarditis and pay extra attention to those who are most at risk," lead study author Dr. Dror Mevorach said in a news release. He is a professor of medicine and head of the Immunology-Rheumatology Institution at Hadassah Ein Karem Medical Center in Jerusalem and chairman of the Israeli Ministry of Health Committee for Identifying Myocarditis as an Adverse Effect of mRNA Vaccines. Myocarditis is an inflammation of the middle layer of the wall of the heart muscle, called the myocardium. It can be triggered by a viral infection and can weaken the heart muscle and the heart's electrical system, which makes it harder for the heart to beat normally. The condition can resolve on its own or with treatment, but also can cause lasting damage to the heart. Previous research from public health agencies around the world, including the U.S. Centers for Disease Control and Prevention, has shown a potential increased risk of myocarditis following an mRNA COVID-19 vaccine. A recent study published by the Ministry of Health in Israel found a low incidence of myocarditis after a first and second dose of Pfizer's vaccine. But because risk was highest among young men and teen boys who had a second dose of the vaccine, researchers were concerned about the potential effect a third dose, the booster dose. In the new study, researchers analyzed health data for people who developed myocarditis following a third dose of the Pfizer vaccine, which was given to nearly 4 million Israeli adults between July 31 and Nov. 5, 2021. Within the first 30 days of receiving the booster, there were 35 reported cases of myocarditis. An additional 56 cases were reported after 30 days. Of those, 28 cases were confirmed or considered probable, and 18 of those occurred within a week of the booster being given. All 28 cases were considered mild. Patients recovered after spending an average of three to four days in the hospital. Across all ages, the risk of developing vaccine-related myocarditis was nine times higher for men than women. Males ages 16-19 faced the highest risk, with young men ages 20-24 having the second-highest risk. The risk of developing myocarditis among males ages 16-19 after a third dose was about 1 in 15,000. Other research shows COVID-19 infection poses a higher risk for myocarditis than vaccines. The risk for developing myocarditis was lower following a booster than following a second dose of the vaccine, the researchers reported. Mevorach suggested two possible reasons for this. As a medical precaution, people who developed myocarditis after the second COVID-19 vaccine dose did not receive a third dose. Also, timing may be a factor. The first and second doses are administered approximately three weeks apart, but the time between a second dose and a booster was about 20 to 24 weeks. Researchers don't know why young men and teenage boys are at higher risk for myocarditis from a COVID-19 vaccine and believe further investigation is needed. If you have questions or comments about this American Heart Association News story, please email [email protected]. American Heart Association News Stories American Heart Association News covers heart disease, stroke and related health issues. Not all views expressed in American Heart Association News stories reflect the official position of the American Heart Association. Statements, conclusions, accuracy and reliability of studies published in American Heart Association scientific journals or presented at American Heart Association scientific meetings are solely those of the study authors and do not necessarily reflect the American Heart Association’s official guidance, policies or positions.Copyright is owned or held by the American Heart Association, Inc., and all rights are reserved. Permission is granted, at no cost and without need for further request, for individuals, media outlets, and non-commercial education and awareness efforts to link to, quote, excerpt or reprint from these stories in any medium as long as no text is altered and proper attribution is made to American Heart Association News. Other uses, including educational products or services sold for profit, must comply with the American Heart Association’s Copyright Permission Guidelines. See full terms of use. These stories may not be used to promote or endorse a commercial product or service. HEALTH CARE DISCLAIMER: This site and its services do not constitute the practice of medical advice, diagnosis or treatment. Always talk to your health care provider for diagnosis and treatment, including your specific medical needs. If you have or suspect that you have a medical problem or condition, please contact a qualified health care professional immediately. If you are in the United States and experiencing a medical emergency, call 911 or call for emergency medical help immediately. Related Articles COVID-19 infection poses higher risk for myocarditis than vaccines Heart complications uncommon, treatable in children with COVID-19 Post-vaccine myocarditis in young people is rare and usually mild, study confirms Popular Articles Heart transplants from donors with hepatitis C may be safe For many people, surviving COVID-19 doesn't mean getting better *All health/medical information on this website has been reviewed and approved by the American Heart Association, based on scientific research and American Heart Association guidelines. Find more information on our content editorial process. Contact Us National Center 7272 Greenville Ave. Dallas, TX 75231 Customer Service 1-800-AHA-USA-1 1-800-242-8721 Contact Us Hours Monday - Friday: 7 a.m. – 7 p.m. CT  Saturday: 9 a.m. - 5 p.m. CT Closed on Sundays Tax Identification Number13-5613797 About Us About Us About the AHA/ASA Annual Report AHA Financial Information International Programs Latest Heart and Stroke News AHA/ASA Media Newsroom Careers Get Involved Get Involved Donate Now Make a Memorial Gift Ways to Give Advocate Volunteer Go Red For Women ShopHeart ShopCPR Our Sites Our Sites American Heart Association American Stroke Association CPR & ECC Professional Heart Daily More Sites AHA Careers Privacy Policy Medical Advice Disclaimer Copyright Policy Accessibility Statement Ethics Policy Conflict of Interest Policy Linking Policy Whistleblower Policy Content Editorial Guidelines Diversity Suppliers & Providers State Fundraising Notices ©2023 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization. *Red Dress ™ DHHS, Go Red ™ AHA ; National Wear Red Day® is a registered trademark. Speed Bump × This link is provided for convenience only and is not an endorsement of either the linked-to entity or any product or service. Proceed